Clinical trials
Heart Valve Diseases trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 3 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ankara City Hospital Bilkent | 2 |
| Ankara Yildirim Beyazıt University | 1 |
| CSL Behring | 1 |
| Centre Chirurgical Marie Lannelongue | 1 |
| Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital | 1 |
| Florence Nightingale Hospital, Istanbul | 1 |
| Istanbul Saglik Bilimleri University | 1 |
| Istanbul University | 1 |
| Istanbul University - Cerrahpasa | 1 |
| Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Valve Diseases | 15 |
| Coronary Artery Disease | 5 |
| Cardiovascular Diseases | 2 |
| Emergence Delirium | 2 |
| Heart Diseases | 2 |
| Postoperative Complications | 2 |
| Acute Coronary Syndrome | 1 |
| Aortic Diseases | 1 |
| Atherosclerosis | 1 |
| Atrial Fibrillation | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.